Top Law News Daiichi-Ranbaxy row: High Court allows sale of Singh brothers’ firms May 9, 2018 by Legal India Admin | Leave a Comment The Delhi High Court today allowed the sale of unencumbered shares of the firms of former promoters of India’s Ranbaxy Laboratories Ltd in listed companies to repay the Rs 3,500 crore arbitration award in favour of Japanese pharma major Daiichi Sankyo. Justice Jayant Nath also directed the debtors to fully cooperate with the chartered accountant […] Read more » Daiichi-Ranbaxy Delhi High Court featured Justice Jayant Nath Malvinder Singh Ranbaxy
Top Law News Andhra HC lifts stay on Ranbaxy, Sun Pharma merger May 26, 2014 by Legal India Admin | Leave a Comment Shares of Sun Pharmaceutical Industries and Ranbaxy Laboratories are trading higher by up to 3% in early morning deals after the Andhra Pradesh High Court cleared the decks for the $4-billion deal to go through by lifting the stay. The Andhra Pradesh High Court on Saturday vacated a status quo order it had issued earlier […] Read more » Merger news Pharma Ranbaxy SEBI Sun Pharma todays news todays top news Top news
Top Law News SC dismisses PIL seeking curbs on sale of Ranbaxy drugs June 26, 2013 by Legal India Admin | Leave a Comment The Supreme Court Tuesday dismissed a petition for prohibiting Ranbaxy from producing and marketing its alleged “adulterated” medicines in the Indian market in the wake of reports of the pharma major having sold misbranded drugs in the US. A bench of Justice A.K.Patnaik and Justice Ranjan Gogoi dismissed the Public Interest Litigation (PIL) by advocate M.L. Sharma, asking him […] Read more » advocate M L Sharma FDA Justice A.K. Patnaik Justice Ranjan Gogoi national news news PIL public interest litigation Ranbaxy SC dismisses PIL seeking curbs on sale of Ranbaxy drugs todays news todays top news Top news US Food and Drug Administration
